Michele Libonati
Impact in
-
- Multiple Sclerosis Research Studies
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
-
- Immunotherapy and Immune Responses 2
- Immunodeficiency and Autoimmune Disorders 2
-
- Multiple Sclerosis Research Studies 3
- Co-authors
- William Sheremata (2 shared papers)Paul O’Connor (1 shared paper)Lance D. Blumhardt (1 shared paper)Katherine Miszkiel (1 shared paper)Catherine M. Dalton (1 shared paper)George P. Rice (1 shared paper)David H. Miller (1 shared paper)Omar Khan (1 shared paper)
- Journals
- Journal of Pediatric Gastroenterology and Nutrition (2 papers)Experimental Neurology (1 paper)Neurology (1 paper)Multiple Sclerosis Journal (1 paper)New England Journal of Medicine (1 paper)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Michele Libonati
8 papers receiving 1.1k citations
Michele Libonati's Hit Papers
Peers
Comparison fields: 5 of 76
- Pathology and Forensic Medicine 626
- Immunology and Allergy 150
- Immunology 439
- Oncology 418
- Neurology 219
Countries citing papers authored by Michele Libonati
This map shows the geographic impact of Michele Libonati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Libonati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Libonati more than expected).
Fields of papers citing papers by Michele Libonati
This network shows the impact of papers produced by Michele Libonati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Libonati. The network helps show where Michele Libonati may publish in the future.
Co-authors
The 25 scholars most cited alongside Michele Libonati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis Hit paper breakdown → | 2003 | 936 |
| 2 | 2004 | 117 | |
| 3 | 2007 | 49 | |
| 4 | 1997 | 41 | |
| 5 | 2004 | 33 | |
| 6 | 1992 | 9 | |
| 7 | 2005 | 7 | |
| 8 | [Research on cephalotoxin. 2. On some pharmacological properties of the substance]. | 1959 | 1 |
About Michele Libonati
Michele Libonati is a scholar working on Immunology, Pathology and Forensic Medicine, Molecular Biology, Cellular and Molecular Neuroscience and Neurology, having authored 8 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (3 papers), Inflammatory Bowel Disease (2 papers), Immunotherapy and Immune Responses (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Neuroscience and Neural Engineering (1 paper), Chemical Reactions and Isotopes (1 paper), Cell Adhesion Molecules Research (1 paper) and Peripheral Neuropathies and Disorders (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (626 citations), Immunology and Allergy (150 citations), Immunology (439 citations), Oncology (418 citations) and Neurology (219 citations). Michele Libonati has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include William Sheremata, Paul O’Connor, Lance D. Blumhardt, Katherine Miszkiel, Catherine M. Dalton, George P. Rice, David H. Miller, Omar Khan, Andrew Goodman and L Metz. Their work appears in journals such as Journal of Pediatric Gastroenterology and Nutrition, Experimental Neurology, Neurology, Multiple Sclerosis Journal and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.